MedPath

Capnography During ERCP

Phase 3
Completed
Conditions
Hypoxemia
Complications
Registration Number
NCT01072474
Lead Sponsor
Technical University of Munich
Brief Summary

In the study the value of capnography for avoiding complications during sedation for ERCP is evaluated.

Detailed Description

In this randomized controlled trial the utility of capnography gets evaluated. Hypoxemia may occur during sedation with midazolam and propofol. Whether hypoxemia may be prevented by an additional capnographic monitoring is subject of the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
242
Inclusion Criteria
  • Age>=18
  • Scheduled for colonoscopy with midazolam and propofol sedation
Exclusion Criteria
  • No informed consent
  • ASA V
  • Pregnancy
  • Prexisting hypotension, bradycardia or hypoxemia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
HypoxemiaFrom the beginning to the end of the ERCP procedure, i.e. from 0h to approximately 2h
Secondary Outcome Measures
NameTimeMethod
Further complicationsFrom the beginning to the end of the ERCP procedure, i.e. from 0h to approximately 2h

Trial Locations

Locations (3)

Technische Universität München

🇩🇪

Munich, Bavaria, Germany

Knappschaftskrankenhaus der Ruhr-Universität Bochum

🇩🇪

Bochum, Germany

Deutsche Klinik für Diagnostik

🇩🇪

Wiesbaden, Germany

Technische Universität München
🇩🇪Munich, Bavaria, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.